Search

Evidence for shared deficits in identifying emotions from faces and from voices in autism spectrum disorders and specific language impairment

While autism spectrum disorder (ASD) and specific language impairment (SLI) have traditionally been conceptualized as distinct disorders, recent findings...

The association between autism and schizophrenia spectrum disorders: A review of eight alternate models of co-occurrence

Understanding how and why these disorders co-occur has important implications for diagnosis, treatment, and prognosis, as well as for developing fundamental...

Moving beyond behaviour-only assessment: Incorporating biomarkers to improve the early detection and diagnosis of autism spectrum disorders

This paper presents a response to the Camarata (2014) lead article regarding the accuracy and effectiveness of early identification and early intervention...

High use of complementary and alternative medication among children with autism is not associated with the severity of core symptoms

This study provided evidence for high rate of alternative medicine use in an Australian paediatric ASD population, similar to other countries.

Brief Report: Further Evidence for a Link Between Inner Speech Limitations and Executive Function in High-Functioning Children with Autism

This study investigated the involvement of inner speech limitations in the executive dysfunction associated with autism spectrum disorders (ASDs).

Caregiver broader autism phenotype does not moderate the effect of early caregiver-mediated support on infant language outcomes

Caregiver-mediated supports in general have shown mixed evidence for enhancing language outcomes in infants at higher likelihood of autism. While caregivers play a substantial role in caregiver-mediated supports, little is known about whether caregivers' own subclinical autistic features - known as broader autism phenotype - may moderate infant language outcomes. 

Autism diagnoses are up, largely fuelled by the NDIS. What happens next isn’t entirely clear

In this article, Deputy Director of the Kids Research Institute Australia, Andrew Whitehouse explores why diagnosis rates have risen and what proposed NDIS reforms could mean for autistic children, families and future access to supports. Published by The Conversation on the 15th April 2026

Evaluating placebo responses to intranasal oxytocin in autism: findings from the placebo lead-in phase of a randomised controlled trial

The placebo effect is established in clinical trials, but for paediatric research, questions remain about how to best manage its influence. Within the autism field, data on these issues is sparse. This is particularly important in the oxytocin field where placebo responses are thought to play an important role. This study reports on data from the single-blind, placebo lead-in phase of a randomised controlled trial to investigate the placebo response and its relationship to treatment response in autistic children. 

Screening all 3‑ and 4‑year‑olds for developmental delay makes sense. But diagnosing autism is different

David Trembath, Head of Autism Research and Senior Principal Research Fellow, at The Kids Research Institute, explains why developmental screening is important and why autism diagnosis requires a comprehensive assessment. Published by The Conversation on the 17th June 2026

Reliability, Validity and Acceptability of the PEDI-CAT with ASD Scales for Australian Children and Youth on the Autism Spectrum

The PEDI-CAT (ASD) is used to assess functioning of children and youth on the autism spectrum; however, current psychometric evidence is limited. This study aimed to explore the reliability, validity and acceptability of the PEDI-CAT (ASD) using a large Australian sample.